Home / Business and Economy / Weight Loss Drugs Chip Away at UK Fish & Chip Sales
Weight Loss Drugs Chip Away at UK Fish & Chip Sales
24 Mar
Summary
- Weight loss jabs are decreasing fish and chip sales significantly.
- Consumers are opting for smaller portions and sharing meals.
- Half of UK fish and chip shops may close without improvements.
Sales of the quintessential British dish, fish and chips, have seen a substantial decrease, with industry leaders attributing the decline to a growing preference for smaller portions. This shift is partly driven by the increasing popularity of weight loss jabs, such as GLP-1 receptor agonists, now used by approximately 1.5 million people in the UK. These medications suppress appetite, leading consumers to order less food and sometimes share larger portions to control spending.
The economic pressures of the cost of living crisis are exacerbated by rising fish prices and energy bills. Consequently, around 10,000 fish and chip shops are facing an uncertain future, with warnings that half could close if conditions do not improve. This economic strain also impacts the agricultural sector, as potato farmers struggle to find buyers for their crops due to reduced demand for chips and processed potato products.
Traditional takeaway habits are evolving, with fish and chips no longer ranking among the top ten most-ordered dishes on major delivery platforms. This decline signals a potential shift in British culinary preferences, with newer international options gaining popularity. The situation is prompting calls for adaptation within the industry, encouraging owners to offer lighter bites and smaller serving sizes to meet changing consumer demands.
